Menu

Barclays Maintains Equal-Weight on Adient, Raises Price Target to $29

Benzinga Newsdesk 6 months ago

NewsPrice TargetAnalyst Ratings

Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and raises the price target from $26 to $29.

Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and raises the price target from $26 to $29.

Read the original